WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • WJPPS: MARCH ISSUE PUBLISHED
  • March Issue has been successfully launched on 1 March 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

Abstract

COMPARATIVE EFFICACY OF TWO ORAL APRAMYCIN FORMULATION (NEOVE APRAMYCIN® AND APRABIOPHAR®) AGAINST EXPERIMENTAL INFECTION WITH ESCHERICHIA COLI IN BROILER BREEDERS

Ashraf El-Komy* and Mohamed Aboubakr

ABSTRACT

This study was conducted to assess the efficacy of apramycin (Neove Apramycin® and Aprabiophar®) in controlling the adverse effects of experimentally induced colibacillosis in broiler breeders. Two hundred, one-day old broiler breeder chicks were used and randomly allocated into three experimental groups; group (1) uninfected-untreated, group (2) infected-untreated, group (3) infected-treated with apramycin (Neove Apramycin)® in the drinking water and group (4) infected-treated with apramycin (Aprabiophar)® in the drinking water. The drug was given at dose level of 25 mg apramycin /kg b.wt/day for 5 consecutive days. Experimental colibacillosis was induced at 21-day of age by IM inoculation of Escherichia coli (E.coli) serotype O78: K80. Clinical signs, mortalities, mean lesion scores, performance including body weight and feed conversion efficiency were recorded and evaluated. The Results showed that infected-apramycin treated chickens had less pronounced clinical signs, significant lower mortalities, higher body weight and better feed conversion than infected-untreated birds. In conclusion, apramycin administration (Neove Apramycin® and Aprabiophar®) at 25 mg apramycin/kg b.wt /day for 5 consecutive days is efficacious for the treatment of colibacillosis in broiler breeders evident by improvement of all investigated parameters. There was no significant changes between Neove Apramycin® and Aprabiophar® and both products can be used as interchangeable drug in veterinary medicine practice especially in poultry.

Keywords: .


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More